IDH1-vac for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Oct 2026: Trial registered, NCT07888647

The trials

NCT07888647: IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas

State
Not started
Phase
Phase 2
People
216 planned
Started
1 Feb 2027
Primary completion
1 Feb 2034
Arms
Vaccination
Results
None posted
  1. 22 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.